An antigen-encapsulating nanoparticle platform for T(H)1/17 immune tolerance therapy

Tolerogenic nanoparticles (NPs) are rapidly being developed as specific immunotherapies to treat autoimmune disease. However, many NP-based therapies conjugate antigen (Ag) directly to the NP posing safety concerns due to antibody binding or require the co-delivery of immunosuppressants to induce to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine
Hauptverfasser: McCarthy, Derrick P., Yap, Jonathan Woon-Teck, Harp, Christopher T., Song, W. Kelsey, Chen, Jeane, Pearson, Ryan M., Miller, Stephen D., Shea, Lonnie D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2016
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5237397/
https://ncbi.nlm.nih.gov/pubmed/27720992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2016.09.007
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge